The Vaccine World MENA & CIS Summit 2014 is dedicated to the vaccine industry in the Middle East, North Africa, CIS and CEE region.
Some interesting facts:
- Pfizer opened a pneumococcal conjugate vaccine (PCV) production plant in Istanbul in November 2012
- MSD and Saudi Biopharma Sobol signed a long-term exclusive agreement to establish a manufacturing plant for certain types of vaccines in Aug 2012
- Israeli vaccine company SciVac is seeking U.S. approval for a widely used hepatitis B vaccine for global expansion in July 2013
- Nanolek announced plans to become the first manufacturer of a VLP (virus-like particle)-based flu vaccine in Russia in May 2013
- GlaxoSmithKline (GSK) has announced plans to produce vaccines in Turkey with local company IDOL in November 2013
Who should Attend
Attendees from vaccine companies from the MENA and CIS region.
